These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 2343075)

  • 21. Cholecystokinin octapeptide and caerulein injection into the dorsomedial nucleus accumbens potentiate apomorphine-induced jaw movements in rats.
    Koshikawa N; Kikuchi de Beltrán K; Saigusa T; Kobayashi M; Stephenson JD
    Eur J Pharmacol; 1991 Dec; 209(1-2):75-80. PubMed ID: 1814762
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The turnover rate of gamma-aminobutyric acid in the nuclei of telencephalon: implications in the pharmacology of antipsychotics and of a minor tranquilizer.
    Mao CC; Marco E; Revuelta A; Bertilsson L; Costa E
    Biol Psychiatry; 1977 Jun; 12(3):359-71. PubMed ID: 17436
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neurochemical effects of nicotine on glutamate and GABA mechanisms in the rat brain.
    Pérez de la Mora M; Méndez-Franco J; Salceda R; Aguirre JA; Fuxe K
    Acta Physiol Scand; 1991 Feb; 141(2):241-50. PubMed ID: 1675543
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Influence of short-lasting bilateral clamping of carotid arteries (BCCA) on GABA turnover in rat brain structures.
    Sieklucka M; Löscher W; Heim C; Sontag KH
    Neurochem Res; 1994 Mar; 19(3):367-72. PubMed ID: 8177378
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Caerulein, a cholecystokinin-related peptide, depresses somatic function via the vagal afferent system.
    Kawasaki K; Kodama M; Matsushita A
    Life Sci; 1983 Sep; 33(11):1045-50. PubMed ID: 6888161
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neurochemical effects of the endocannabinoid uptake inhibitor UCM707 in various rat brain regions.
    de Lago E; Ortega-Gutiérrez S; Ramos JA; López Rodríguez ML; Fernández-Ruiz J
    Life Sci; 2007 Feb; 80(10):979-88. PubMed ID: 17173937
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Action of peripherally administered cholecystokinin on monoaminergic and GABAergic neurons in the rat brain.
    Kaneyuki T; Morimasa T; Shohmori T
    Acta Med Okayama; 1989 Jun; 43(3):153-9. PubMed ID: 2763865
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gamma-aminobutyric acid turnover in rat striatum: effects of glutamate and kainic acid.
    Giorgi O; Meek JL
    J Neurochem; 1984 Jan; 42(1):215-20. PubMed ID: 6139420
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-lasting inhibitory action of caerulein on climbing fiber system in the cerebellum of the rat.
    Kageyama H; Kurosawa A
    Neuropharmacology; 1989 Sep; 28(9):991-5. PubMed ID: 2554189
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of anticonvulsants and gamma-aminobutyric acid (GABA)-mimetic drugs on immunoreactive somatostatin and GABA contents in the rat brain.
    Nagaki S; Kato N; Minatogawa Y; Higuchi T
    Life Sci; 1990; 46(22):1587-95. PubMed ID: 1972258
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Iron concentration reduced in ventral pallidum, globus pallidus, and substantia nigra by GABA-transaminase inhibitor, gamma-vinyl GABA.
    Hill JM
    Brain Res; 1985 Sep; 342(1):18-25. PubMed ID: 4041811
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The cholecystokinin analogue, caerulein, does not modulate dopamine release or dopamine-induced locomotor activity in the nucleus accumbens of rat.
    Hamilton M; Sheehan MJ; De Belleroche J; Herberg LJ
    Neurosci Lett; 1984 Jan; 44(1):77-82. PubMed ID: 6717857
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vivo effects of anticonvulsant drugs on nerve terminal (synaptosomal) GABA levels in 11 brain regions of the rat.
    Löscher W; Vetter M; Böhme G; Stoltenburg-Didinger G
    J Neural Transm; 1985; 63(2):157-67. PubMed ID: 3930660
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Regional differences in the changes in rat brain GABA concentrations post mortem and following inhibition of the synthesis and metabolism.
    Andén NE; Lindgren S; Magnusson A
    Pharmacol Toxicol; 1987 May; 60(5):393-6. PubMed ID: 3615349
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An analysis of the mechanism by which gamma-aminobutyric acid depresses ventilation in the rat.
    Hedner J; Hedner T; Wessberg P; Jonason J
    J Appl Physiol Respir Environ Exerc Physiol; 1984 Apr; 56(4):849-56. PubMed ID: 6725063
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Stress-induced alterations in metabolism of gamma-aminobutyric acid in rat brain.
    Yoneda Y; Kanmori K; Ida S; Kuriyama K
    J Neurochem; 1983 Feb; 40(2):350-6. PubMed ID: 6130124
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The antimyoclonic action of clonazepam through a GABA--independent mechanism.
    Paul V; Krishnamoorthy MS
    Indian J Physiol Pharmacol; 1989; 33(4):243-6. PubMed ID: 2620967
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of milacemide, a glycinamide derivative, on the rat brain gamma-aminobutyric acid system.
    de Varebeke PJ; Niebes P; Pauwels G; Roba J; Korf J
    Biochem Pharmacol; 1983 Sep; 32(18):2751-5. PubMed ID: 6414480
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of dopamine agonists on gamma-aminobutyric acid (GABA) turnover in the superior colliculus: evidence that nigrotectal GABA projections are under the influence of dopaminergic transmission.
    Melis MR; Gale K
    J Pharmacol Exp Ther; 1983 Aug; 226(2):425-31. PubMed ID: 6875856
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Constant infusion of [13C6]glucose: simultaneous measurement of turnover of GABA and glutamate in defined regions of the brain of individual animals.
    Wood PL; Kim HS; Cheney DL; Cosi C; Marien M; Rao TS; Martin LL
    Neuropharmacology; 1988 Jul; 27(7):669-76. PubMed ID: 3419548
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.